Ionis to hold fourth quarter and full year 2024 financial results webcast
Ionis Pharmaceuticals (Nasdaq: IONS) has announced a webcast scheduled for Wednesday, February 19th at 11:30 a.m. Eastern Time. During this event, the company will discuss its fourth quarter and full year 2024 financial results. The webcast will be accessible through the company's investor relations website, and a replay will be available for a time afterward.
Ionis Pharmaceuticals (Nasdaq: IONS) ha annunciato un webcast programmato per mercoledì 19 febbraio alle 11:30, ora orientale. Durante questo evento, l'azienda discuterà i risultati finanziari del quarto trimestre e dell'intero anno 2024. Il webcast sarà accessibile attraverso il sito web delle relazioni con gli investitori dell'azienda, e un replay sarà disponibile per un certo periodo di tempo dopo.
Ionis Pharmaceuticals (Nasdaq: IONS) ha anunciado un webcast programado para el miércoles 19 de febrero a las 11:30 a.m., hora del este. Durante este evento, la compañía discutirá sus resultados financieros del cuarto trimestre y del año completo 2024. El webcast será accesible a través del sitio web de relaciones con inversionistas de la compañía, y habrá una reproducción disponible por un tiempo después.
아이오니스 제약(Ionis Pharmaceuticals, Nasdaq: IONS)이 2월 19일 수요일 오전 11시 30분(동부 표준시)에 예정된 웹캐스트를 발표했습니다. 이 행사에서 회사는 2024년 4분기 및 전체 연도 재무 결과에 대해 논의할 것입니다. 웹캐스트는 회사의 투자자 관계 웹사이트를 통해 접속 가능하며, 이후 일정 기간 동안 다시 볼 수 있습니다.
Ionis Pharmaceuticals (Nasdaq: IONS) a annoncé un webcast prévu pour mercredi 19 février à 11h30, heure de l'Est. Pendant cet événement, l'entreprise discutera de ses résultats financiers du quatrième trimestre et de l'année complète 2024. Le webcast sera accessible via le site web des relations investisseurs de l'entreprise, et un replay sera disponible pendant un certain temps après.
Ionis Pharmaceuticals (Nasdaq: IONS) hat ein Webcast für Mittwoch, den 19. Februar um 11:30 Uhr Eastern Time angekündigt. Während dieser Veranstaltung wird das Unternehmen seine Finanzergebnisse für das vierte Quartal und das gesamte Jahr 2024 besprechen. Der Webcast wird über die Investoren-Relations-Website des Unternehmens zugänglich sein, und eine Wiederholung wird für eine gewisse Zeit danach verfügbar sein.
- None.
- None.
Webcast scheduled for Wednesday, February 19 at 11:30 a.m. Eastern Time
The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address.
About Ionis Pharmaceuticals, Inc.
For three decades, Ionis has invented medicines that bring better futures to people with serious diseases. Ionis currently has six marketed medicines and a leading pipeline in innovative late- and mid-stage pipeline across our focus areas of neurology, cardiology and rare diseases. As the pioneer in RNA-targeted medicines, Ionis continues to drive innovation in RNA therapies in addition to advancing new approaches in gene editing. A deep understanding of disease biology and industry-leading technology propels our work, coupled with a passion and urgency to deliver life-changing advances for patients. To learn more about Ionis, visit Ionis.com and follow us on X (Twitter) and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250205906526/en/
Ionis Pharmaceuticals Investor Contact:
D. Wade Walke, Ph.D. – IR@ionis.com – 760-603-2331
Ionis Pharmaceuticals Media Contact:
Hayley Soffer – media@ionis.com – 760-603-4679
Source: Ionis Pharmaceuticals, Inc.
FAQ
When will Ionis Pharmaceuticals (IONS) release Q4 and full year 2024 earnings?
How can investors access the IONS Q4 2024 earnings webcast?
What financial results will IONS discuss in their February 19th webcast?
Will there be a replay available for the IONS Q4 2024 earnings webcast?
